Biophytis Delays 20-F Filing Due to Exceptional Circumstances
| Field | Detail |
|---|---|
| Company | Biophytis SA |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-delay, annual-report, regulatory
TL;DR
Biophytis 20-F filing delayed, citing 'exceptional circumstances'.
AI Summary
On June 2, 2025, Biophytis S.A. announced a press release stating that due to exceptional circumstances, they are delaying the filing of their annual report on Form 20-F. The company is working to complete the report as soon as possible.
Why It Matters
This delay could impact investor confidence and potentially affect the company's stock price due to uncertainty surrounding its financial reporting.
Risk Assessment
Risk Level: medium — Delays in SEC filings can signal underlying issues and create uncertainty for investors.
Key Players & Entities
- Biophytis S.A. (company) — Registrant
- June 2, 2025 (date) — Date of press release and report
- Form 20-F (document) — Annual report form
FAQ
What are the 'exceptional circumstances' causing the delay?
The filing does not specify the exact nature of the 'exceptional circumstances' but states they are the reason for the delay in filing the Form 20-F.
When does Biophytis expect to file its Form 20-F?
The filing states the company is working to complete the report as soon as possible, but no specific new date is provided.
What is a Form 20-F?
A Form 20-F is an annual report required by the U.S. Securities and Exchange Commission (SEC) for foreign private issuers.
What is the Commission File Number for Biophytis?
The Commission File Number for Biophytis S.A. is 001-38974.
Where is Biophytis S.A. headquartered?
Biophytis S.A. is located at Sorbonne University—BC 9, Bâtiment A 4ème étage, 4 place Jussieu, 75005 Paris, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding Biophytis SA.